Completed PHASE4 INTERVENTIONAL 2-arm NCT04694300

OTC Naproxen and Acetaminophen Anti-Inflammatory Action in Dental Implant Patients

Demonstration of OTC Naproxen Sodium's (Aleve's) Anti-inflammatory Action in Dental Implant Surgery Patients

Sponsor: Hersh, Elliot V., DMD, MS, PhD

Conditions Osseointegrated Dental Implantation Pain, Acute

Interventions Acetaminophen Naproxen Tramadol

Updated 6 times since 2021 Last updated: May 7, 2024 Started: Feb 7, 2021 Primary completion: Aug 28, 2022 Completion: Aug 28, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04694300, this PHASE4 trial focuses on Osseointegrated Dental Implantation and Pain, Acute and remains completed. Sponsored by Hersh, Elliot V., DMD, MS, PhD, it has been updated 6 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jun 2024 — Jul 2024 [monthly]

Completed PHASE4
Nov 2022 — Jun 2024 [monthly]

Completed PHASE4

Status: Recruiting → Completed
Mar 2021 — Nov 2022 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Feb 2021 — Mar 2021 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hersh, Elliot V., DMD, MS, PhD
University of Pennsylvania

Data source: Hersh, Elliot V., DMD, MS, PhD

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Philadelphia, United States